Cristin

2014
1.	Omvik, Per; Lund-Johansen, Per. Hemodynamics and Hypertension. I: Manual of Hypertension of the European Society of Hypertension. Taylor & Francis 2014 ISBN 978-1-84184-997-3. s. 101-114 UiB Untitled
2012
2.	Greve, Anders M.; Olsen, Michael Hecht; Bella, Jonathan N.; Lønnebakken, Mai Tone; Gerdts, Eva; Okin, Peter M.; Palmieri, Vittorio; Boman, Kurt; Nieminen, Markku S.; Omvik, Per; Dahlöf, Björn; Devereux, Richard B.; Wachtell, Kristian. Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: A LIFE study. American Journal of Hypertension 2012 ;Volum 25.(9) s. 1017-1023 HAUKELAND UiB Untitled
2011
3.	Olsen, Michael Hecht; Wachtell, Kristian; Ibsen, Hans; Lindholm, Lars; Kjeldsen, Sverre Erik; Omvik, Per; Nieminen, Markku S.; Dahlöf, Björn; Okin, Peter M.; Devereux, Richard B.. Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy. Journal of Hypertension 2011 ;Volum 29.(5) s. 997-1004 HAUKELAND OUS Untitled
2009
4.	Davidsen, Einar Skulstad; Hervig, Tor; Omvik, Per; Gerdts, Eva. Left ventricular long-axis function in treated haemochromatosis. The International Journal of Cardiac Imaging 2009 ;Volum 25.(3) s. 237-247 UiB HAUKELAND Untitled

5.	Davidsen, Einar Skulstad; Omvik, Per; Hervig, Tor; Gerdts, Eva. Left ventricular diastolic function in patients with treated haemochromatosis. Scandinavian Cardiovascular Journal 2009 ;Volum 43.(1) s. 32-38 UiB HAUKELAND Untitled

6.	Gerdts, Eva; Okin, Peter M.; Omvik, Per; Wachtell, Kristian; Dahlöf, Björn; Hildebrandt, Per R.; Nieminen, Markku S.; Devereux, Richard B.. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study. NMCD. Nutrition Metabolism and Cardiovascular Diseases 2009 ;Volum 19.(5) s. 306-312 UiB HAUKELAND Untitled

7.	hecht olsen, michael; Wachtell, Kristian; Beevers, Gareth; Dahlöf, Björn; de Simone, Giovanni; devereux, richard b; de Faire, Ulf; Fyhrquist, Frej; Ibsen, Hans; Kjeldsen, Sverre E.; Lederballe-Pedersen, Ole; Lindholm, Lars H; Lyle, Paulette A.; Nieminen, Markku S; Omvik, Per; Oparil, Suzanne; Wedel, Hans. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension 2009 ;Volum 18. s. 567-574 UiB Untitled

8.	Kjeldsen, Sverre E.; Devereux, Richard B; Hille, Darcy A.; Lyle, Paulette A.; Dahlöf, Björn; Julius, Stevo; Edelman, Jonathan M.; Snapinn, Steven M.; de Faire, Ulf; Fyhrquist, Frej; Ibsen, Hans; Lederballe-Pedersen, Ole; Lindholm, Lars H; Nieminen, Markku S; Omvik, Per; Oparil, Suzanne; Wedel, Hans. Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study. Blood Pressure 2009 ;Volum 18.(6) s. 348-361 UiB HAUKELAND UiO Untitled

9.	Olsen, Michael Hecht; Wachtell, Kristian; Beevers, Gareth; Dahlöf, Björn; de Simone, Giovanni; Devereux, Richard B.; De Faire, Ulf; Fyhrquist, Frej; Ibsen, Hans; Kjeldsen, Sverre Erik; Lederballe-Pedersen, Ole; Lindholm, Lars; Lyle, Paulette A.; Nieminen, Markku S.; Omvik, Per; Oparil, Suzanne; Wedel, Hans. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan intervention For Endpoint reduction in hypertension study. Journal of Hypertension 2009 ;Volum 27.(3) s. 567-574 OUS HAUKELAND Untitled

10.	Olsen, Michael Hecht; Wachtell, Kristian; Beevers, Gareth; Dahlöf, Björn; Devereux, Richard B.; De Faire, Ulf; Fyhrquist, Frej; Ibsen, Hans; Kjeldsen, Sverre Erik; Lederballe-Pedersen, Ole; Lindholm, Lars H.; Narayan, Puneet; Nieminen, Markku S.; Omvik, Per; Oparil, Suzanne; Wedel, Hans. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study. American Heart Journal 2009 ;Volum 157.(1) s. 177-184 UiB OUS Untitled

11.	Omvik, Per; Lund-Johansen, Per. Central haemodynamics of hypertension. Archives of Medical Science 2009 ;Volum 5.(2A) Suppl. S s. 220-228 UiB Untitled
2008
12.	Olsen, MH; Wachtell, K; Beevers, G; Dahlöf, B.; Devereux, RB; de Faire, U; Fyhrquist, F; Ibsen, H; Kjeldsen, Sverre Erik; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. American Heart Journal 2008 ;Volum 157.(1) s. 177-184 UiO Untitled

13.	Olsen, MH; Wachtell, K; Beevers, G; Dahlof, B; Simone, G; Devereux, RB; Faire, U; Fyhrquist, F; Ibsen, H; Kjeldsen, Sverre Erik; Lederballe-Pedersen, O; Lyle, PS; Nieminen, MN; Omvik, P; Wedel, H. Losartan compared with atenolol has positive effects on lipid metabolism in patients with hypertension and left ventricular hypertrophy: The LIFE Study. Journal of Hypertension 2008 UiO Untitled
2007
14.	Davidsen, Einar Skulstad; Liseth, Knut; Omvik, Per; Hervig, Tor; Gerdts, Eva. Reduced exercise capacity in genetic haemochromatosis. European Journal of Cardiovascular Prevention & Rehabilitation 2007 ;Volum 14.(3) s. 470-475 UiB HAUKELAND Untitled

15.	Gerdts, Eva; Wachtell, Kristian; Omvik, Per; Otterstad, Jan Erik; Oikarinen, Lasse; Boman, Kurt; Dahlöf, Björn; Devereux, Richard B.. Left atrial size and risk of major cardiovascular events during antihypertensive treatment - Losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007 ;Volum 49.(2) s. 311-316 UiB SIV Untitled
2006
16.	Gerdts, Eva; Bjørnstad, Hans; Devereux, Richard B.; Lund-Johansen, Per; Davidsen, Einar Skulstad; Omvik, Per. Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). Blood Pressure 2006 ;Volum 15.(4) s. 220-226 UiB Untitled
2005
17.	De Simone, G; Wachtell, K; Palmieri, V; Hille, DA; Beevers, G; Dahlof, B; de Faire, U; Fyhrquist, F; Ibsen, H; Julius, S; Kjeldsen, Sverre Erik; Lederballe-Pedersen, O; Lindholm, LH; Omvik, P; Oparil, S; Devereux, RB. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study. Circulation 2005 ;Volum 111(15). s. 1924-1931 UiO OUS Untitled

18.	Fossum, E; Moan, A; Kjeldsen, Sverre Erik; Devereux, RB; Julius, S; Snapinn, SM; Edelman, JM; de Faire, U; Fyhrquist, F; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H; Dahlof, B. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study. Journal of the American College of Cardiology 2005 ;Volum 46(5). s. 770-775 UiO OUS Untitled

19.	Fyhrquist, F; Dahlof, B; Devereux, RB; Kjeldsen, Sverre Erik; Julius, S; Beevers, G; de Faire, U; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Hille, DA; Lyle, PA; Edelman, JM; Snapinn, SM; Wedel, H. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy. Hypertension 2005 ;Volum 45(4). s. 580-585 UiO OUS Untitled

20.	Ibsen, H; Olsen, MH; Wachtell, K; Borch-Johnsen, K; Lindholm, LH; Mogensen, CE; Dahlof, B; Devereux, RB; de Faire, U; Fyhrquist, F; Julius, S; Kjeldsen, Sverre Erik; Lederballe-Pedersen, O; Nieminen, MS; Omvik, P; Oparil, S; Wan, Y. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005 ;Volum 45(2). s. 198-202 UiO OUS Untitled

21.	Kizer, JR; Dahlof, B; Kjeldsen, Sverre Erik; Julius, S; Beevers, G; de Faire, U; Fyhrquist, F; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H; Wachtell, K; Edelman, JM; Snapinn, SM; Harris, KE; Devereux, RB. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Hypertension 2005 ;Volum 45(1). s. 46-52 UiO OUS Untitled

22.	Kjeldsen, SE; Lyle, PA; Kizer, JR; Dahløf, B; Devereux, RB; Julius, S; Beevers, G; De Faire, U.; Fyhrquist, F; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, Per; Oparil, S; Snapinn, Steven M.; Harris, KE; Wedel, H. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study. The Journal of Clinical Hypertension 2005 ;Volum 7.(3) s. 152-158 UiB Untitled

23.	Kjeldsen, Sverre Erik; Lyle, PA; Kizer, JR; Dahlof, B; Devereux, RB; Julius, S; Beevers, G; de Faire, U; Fyhrquist, F; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Snapinn, SM; Harris, KE; Wedel, H. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study. Journal of Hypertension 2005 ;Volum 7(3). s. 152-158 UiO OUS Untitled

24.	Staal, Eva M; Nygard, Ottar K; Omvik, Per; Gerdts, Eva. Influence of hypertension on angiographic findings in patients with angina pectoris. American Journal of Hypertension 2005 ;Volum 18.(Part II) s. 175A- UiB HAUKELAND Untitled
2004
25.	Donkor, S.; Gordon, S.; Omvik, Per; Gerdts, Eva. Blood pressure and cardiovascular risk factors in hypertensive patients referred to a regional hospital in Ghana. American Journal of Hypertension 2004 ;Volum 17.(Part II) s. A196- UiB Untitled

26.	Ibsen, H.; Wachtell, K.; Olsen, M.H.; Borch-Johnsen, K.; Lindholm, L.H.; Mogensen, C.E.; Dahlof, B.; Devereux, R.B.; De Faire, U.; Fyhrquist, F.; Julius, S.; Kjeldsen, S.E.; Lederballe-Pedersen, O.; Nieminen, M.S.; Omvik, Per; Oparil, S.; Wan, Y.. Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. Journal of Hypertension 2004 ;Volum 22.(9) s. 1805-1811 UiB Untitled

27.	Omvik, Per; Lund-Johansen, Per. Hvorfor ikke alltid diuretika?. Tidsskrift for Den norske legeforening 2004 ;Volum 124. s. 1419-1420 UiB Untitled

28.	Reims, H.M.; Kjeldsen, S.E.; Brady, W.E.; Dahlof, B.; Devereux, R.B.; Julius, S.; Beevers, G.; De Faire, U.; Fyhrquist, F.; Ibsen, H.; Kristianson, K.; Lederballe-Pedersen, O.; Lindholm, L.H.; Nieminen, M.S.; Omvik, Per; Oparil, S.; Wedel, H.. Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study. Journal of Human Hypertension 2004 ;Volum 18.(6) s. 381-389 UiB Untitled

29.	Reims, H.M.; Oparil, S.; Kjeldsen, S.E.; Devereux, R.B.; Julius, S.; Brady, W.E.; Fyhrquist, F.; Ibsen, H.; Lindholm, L.H.; Omvik, Per. Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: The LIFE study. Blood Pressure 2004 ;Volum 13. s. 376-384 UiB Untitled

30.	Staal, E.M.; Nygård, Ottar; Omvik, Per; Gerdts, Eva. Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. Blood Pressure Monitoring 2004 ;Volum 9.(3) s. 167-172 UiB Untitled

31.	Gerdts, Eva; Omvik, Per; Mo, Rune; Kjeldsen, S.E.. Hypertensjon og hjertesykdom. Tidsskrift for Den norske legeforening 2004 ;Volum 124.(6) s. 802-805 UiB Untitled

32.	Hoieggen, A; Alderman, M.H.; Kjeldsen, SE; Julius, S.; Devereux, R.B.; De Faire, U.; Fyhrquist, F.; Ibsen, H.; Kristianson, K.; Lederballe-Pedersen, O.; Lindholm, L.H.; Nieminen, M.S.; Omvik, Per; Oparil, S.; Wedel, H.; Chen, C.; Dahlof, B.. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney International 2004 ;Volum 66.(4) s. 1014-1049 UiB Untitled

33.	Ibsen, H; Wachtell, K; Olsen, MH; Borch-Johnsen, K; Lindholm, LH; Mogensen, CE; Dahlof, B; Devereux, RB; de Faire, U; Fyhrquist, F; Julius, S; Kjeldsen, SE; Lederballe-Pedersen, O; Nieminen, MS; Omvik, Per; Oparil, S; Wan, Y. Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. Journal of Hypertension 2004 ;Volum 22. s. 1805-1811 UiO UiB Untitled

34.	Omvik, Per; Bratland, Bjørn; Gerhardsen, Gerhard; Gisholt, Kjell; Risanger, Terje; Smedsrud, Tore; Kjeldsen, S.E.. Behandling av høyt blodtrykk hos pasienter med venstre<BR/>ventrikkel-hypertrofi. Tidsskrift for Den norske legeforening 2004 ;Volum 104. s. 788-791 UiB Untitled
2003
35.	Devereux, R.B.; Dahlof, B.; Kjeldsen, S.E.; Julius, S.; Aurup, P.; Beevers, G.; Edelman, J. M.; de Faire, U.; Farbu, E; Helle Berg, S.; Ibsen, H.; Kristianson, K.; Lederballe-Pedersen, O.; Lindholm, L.H.; Nieminen, M.S.; Omvik, Per; Oparil, S.; Snapinn, Steven M.; Wedel, H.. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial. Annals of Internal Medicine 2003 ;Volum 139.(3) s. 169-177 UiB Untitled

36.	Gerdts, Eva; Wachtell, Kristian; Omvik, Per; Otterstad, Jan Erik; Oikarinen, Lasse; Boman, Kurt; Devereux, Richard B. Left atrial size and risk of major cardiovascular events in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial). American Heart Scientific Sessions 2003; 2003-11-08 - 2003-11-12 UiB Untitled

37.	Omvik, Per. Allergi, astma og livsstil - epidemiologisk grunnlag - utbredelse. Fagbladet Allergi i praksis 2003 (1) s. 7-9 UiB Untitled

38.	Omvik, Per; Gerhardsen, G.. The Norwegian office-, home-, and ambulatory blood pressure study (NOHA). Blood Pressure 2003 ;Volum 12.(4) s. 211-219 UiB Untitled

39.	Staal, Eva; Omvik, Per; Davidsen, Einar S; Hervold, Anders; Karlsson, Hjobartur D; Lønnebakken, Mai Tone; Schuster, Peter; Hovstad, Thomas; Nygård, Ottar; Gerdts, Eva. Comparison of blood pressure measurements by the Keito machine to casual blood pressure measured by physicians. Norsk Cardiologisk Selskaps Vårmøte; 2003-05-22 - 2003-05-24 UiB Untitled

40.	Wachtell, Kristian; Ibsen, H.; Olsen, M. H.; Borch-Johnsen, K.; Lindholm, L.H.; Mogensen, C.E.; Dahlof, B.; Devereux, R.B.; Beevers, G.; de Faire, U.; Fyhrquist, F.; Julius, S.; Kjeldsen, S.E.; Kristianson, K.; Lederballe-Pedersen, O.; Nieminen, M.S.; Okin, P.M.; Omvik, Per; Oparil, S.; Wedel, H.; Snapinn, Steven M.; Aurup, P.. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Annals of Internal Medicine 2003 ;Volum 139.(11) s. 901-906 UiB Untitled
2002
41.	Dahløf, Bjørn; Devereux, Richard B.; Kjeldsen, Sverre E.; Julius, Stevo; Beevers, Gareth; de Faire, Ulf; Fyhrquist, Frej; Ibsen, Hans; Kristiansson, Krister; Lederballe-Pedersen, Ole; Lindholm, Lars H.; Nieminen, Markku S.; Omvik, Per; Oparil, Suzanne; Wedel, Hans. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet 2002 ;Volum 359. s. 995-1003 UiB Untitled

42.	Gerdts, Eva; Bjørnstad, Hans; Toft, Sigurd; Devereux, Richard B.; Omvik, Per. Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). Journal of Hypertension 2002 ;Volum 20.(6) s. 1223-1229 UiB Untitled

43.	Gerdts, Eva; Wachtell, Kristian; Liu, Jennifer E.; Boman, Kurt; Aalto, Tapio; Omvik, Per. The impact of concomitant diabtes on changes in left ventricular structure and function during antihypertensive treatment (the LIFE study). American Heart; 2002-11-01 UiB Untitled

44.	Kjeldsen, Sverre E.; Dahløf, Bjørn; Devereux, Richard B.; Julius, Stevo; Aurup, Peter; Edelman, Jonathan; Beevers, Gareth; de Faire, Ulf; Fyhrquist, Frej; Ibsen, Hans; Kristiansson, Krister; Lederballe-Pedersen, Ole; Lindholm, Lars H.; Nieminen, Markku; Omvik, Per; Oparil, Suzanne; Snapinn, Steven M.; Wedel, Hans. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. Journal of the American Medical Association (JAMA) 2002 ;Volum 288.(12) s. 1491-1498 UiB Untitled

45.	Lindholm, Lars H.; Ibsen, Hans; Borch-Johnsen, Knut; Olsen, Michael Hecht; Wachtell, Kristian; Dahløf, Bjørn; Devereux, Richard B.; Beevers, Gareth; de Faire, Ulf; Fyhrquist, Frej; Julius, Stevo; Kjeldsen, Sverre E.; Kristiansson, Krister; Lederballe-Pedersen, Ole; Nieminen, Markku S.; Omvik, Per; Oparil, Suzanne; Wedel, Hans; Aurup, Peter; Edelman, Jonathan; Snapinn, Steven M.. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension 2002 ;Volum 20.(9) s. 1879-1886 UiB Untitled

46.	Lindholm, Lars H.; Ibsen, Hans; Dahløf, Bjørn; Devereux, Richard B.; Beevers, Gareth; de Faire, Ulf; Fyhrquist, Frej; Julius, Stevo; Kjeldsen, Sverre E.; Kristiansson, Krister; Lederballe-Pedersen, Ole; Nieminen, Markku S.; Omvik, Per; Oparil, Suzanne; Wedel, Hans; Aurup, Peter; Edelman, Jonathan. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet 2002 ;Volum 359. s. 1004-1010 UiB Untitled

47.	Olsen, Roy; Amlie, Aina; Omvik, Per. Twenty-four-hour ambulatory blood pressure monitoring in atrial fibrillation. Blood Pressure Monitoring 2002 ;Volum 7.(3) s. 149-156 UiB Untitled
2001
48.	Doyle, J.; Omvik, Per; Arikian, S.; Casciano, J.; Casciano, R.; Gonzalez, M. A.; Arocho, R.. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension. Managed Care Interface 2001 ;Volum 14.(3) s. 82-87 UiB Untitled

49.	Svarstad, Einar; Gerdts, Eva; Omvik, Per; Ofstad, Jarle; Iversen, Bjarne Magnus. Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus. Kidney and Blood Pressure Research 2001 ;Volum 24. s. 64-70 UiB Untitled
2000
50.	Björnstad, H; Devereux, RB; Omvik, Per; Gerdts, Eva. Reduction in left ventricular mass and blood pressure is not accompanied by improved exercise performance in hypertensive patients with left ventricular hypertrophy. The LIFE Study; 2000-01-01 UiB Untitled

Vis neste liste